side effects from glp 1 patches what are of GLP-1 vs Injection: Benefits, Risks & Results what are the side effects Quantity:1 Month Supply Supplement ✨ GLP-1 Microdosing: Hype

side effects from glp 1 patches what are of GLP-1 vs Injection: Benefits, Risks & Results what are the side effects Quantity:1 Month Supply Supplement ✨ GLP-1 Microdosing: Hype

✨ GLP-1 Microdosing: Hype or Helpful? ✨ You've probably heard the buzz around GLP-1 medications — but what is microdosing, and who might it actually benefit? In our latest blog, we break

Certainty of evidence was evaluated using the GRADE methodology

Supplement

Quantity:1 Month Supply

A Maryland Biotech Moving on a Tight Timeline Jerry Durso, Altimmune’s CEO and Chairman, pointed to the pace of execution as much as the science: “In just three months, we moved from securing funding for PERFORMA to initiating the trial, reinforcing Altimmune’s commitment to execute with speed and efficiency.” Christophe Arbet-Engels, MD, PhD, Altimmune’s Chief Medical Officer, described the therapeutic logic behind the drug directly: the balanced glucagon/GLP-1 agonism provides “direct effects on the liver, as well as metabolic benefits.” Naim Alkhouri, MD, Chief Medical Officer at Summit Clinical Research and a principal investigator on the trial, framed the broader clinical need: “MASH is a complex disease, and as clinicians, we need therapies that can effectively address both liver disease and the broader metabolic dysfunction that contributes to long-term health risks.” For Maryland’s biotech corridor, this is a notable one to watch